H. Sun

发表

KPT-330 has antitumour activity against non-small cell lung cancer

H. P. Koeffler, Haibo Sun, Q. Sun, 2014, British Journal of Cancer.

A phase I study of a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody “EMD72000 (Matuzumab)” administered weekly in Japanese patients with advanced solid tumors; safety, PK and PD results of skin biopsies

N. Saijo, F. Rojo, A. Ohtsu, 2005 .

Overexpression of PKMYT1 indicates the poor prognosis and enhances proliferation and tumorigenesis in non-small cell lung cancer via activation of Notch signal pathway.

H. Sun, H-M Zhao, Qingsong Sun, 2019, European review for medical and pharmacological sciences.

Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS.

T. Mitsudomi, S. Peters, D. Planchard, 2019, Annals of Oncology.

Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy.

V. Rusch, M. Bains, I. Sarkaria, 2014, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS

T. Mitsudomi, S. Peters, D. Planchard, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase (Ph) II study of MBG453 + spartalizumab in patients (pts) with non-small cell lung cancer (NSCLC) and melanoma pretreated with anti–PD-1/L1 therapy

G. Curigliano, A. Santoro, S. Gutzwiller, 2019, Annals of Oncology.

Adjuvant chemotherapy in completely resected stage III-N2 non-small cell lung cancer.

H. Sun, W. Ou, Q. Fang, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genitourinary tumors, non-prostate

S. J. Park, I. Tannock, S. Groshen, 2012 .

Open access to journal articles in oncology: current situation and citation impact

H. Worthington, A. Glenny, F. Hua, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07.

R. Winterhalder, G. Bodoky, F. Bosman, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Effect of Chinese herbal compound LC09 on patients with capecitabine-associated hand-foot syndrome: A randomized, double-blind, placebo-controlled trial

Y. Lou, L. Jia, T. He, 2019, Annals of Oncology.

Serum biomarkers analyzed by LC-MS/MS as predictors for short outcome of non-small cell lung cancer patients treated with chemoradiotherapy.

Y. Yi, M. Fan, T. Zhou, 2013, Neoplasma.

276P Dalpiciclib, a novel CDK4/6 inhibitor, combined with pyrotinib for HER2+ advanced breast cancer: Interim results of a phase II trial

Ming Yan, Zhangsuo Liu, Jufeng Wang, 2021, Annals of Oncology.

[Clinicopathologic features and prognosis of inflammatory pseudotumor-like follicular dendritic cell sarcomas in liver and spleen: an analysis of seven cases].

L. Yang, H. Sun, F. Wu, 2018, Zhonghua bing li xue za zhi = Chinese journal of pathology.